Preventing sudden cardiac death (SCD) in early non-ischaemic cardiomyopathy (NICM) remains a major clinical challenge. Traditional risk stratification centred on left ventricular ejection fraction (LVEF) poorly captures arrhythmic risk, particularly in early dilated cardiomyopathy (DCM) and non-dilated left ventricular...
A. Kasiakogias, C. Antoniou, T. Tsampras et al.· Frontiers in Cardiovascular...· 0 citations
Background: Diagnoses of transthyretin amyloid cardiomyopathy (ATTR-CM) have increased in recent years, with a growing proportion of patients being identified at earlier disease stages. However, temporal trends in ATTR-CM diagnosis and survival during the tafamidis era in the Greek population remain largely unknown. Me...
F. Kourti, A. Antonopoulos, V. Kytinos et al.· Diagnostics· 0 citations
Patients undergoing transcatheter aortic valve implantation (TAVI) for severe aortic stenosis (AS) have a relatively high prevalence prevalence of Transthyretin cardiac amyloidosis (ATTR), yet optimal screening strategies have not been clearly established.
To develop and validate an easily utilized risk sc...
A. Antonopoulos, T. Tsampras, N. Ktenopoulos et al.· European Heart Journal· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.